azathioprine, Quantity: 50 mg - arama sonuçları

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alcept 250 mycophenolate mofetil 250 mg capsule blister pack

pharmacor pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule - excipient ingredients: magnesium stearate; croscarmellose sodium; pregelatinised maize starch; povidone; titanium dioxide; indigo carmine; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - alcept 250 is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. alcept 250 is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pharmacor mycophenolate 250 mycophenolate mofetil 250 mg capsule blister pack

pharmacor pty ltd - mycophenolate mofetil, quantity: 250 mg - capsule - excipient ingredients: pregelatinised maize starch; povidone; croscarmellose sodium; magnesium stearate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; indigo carmine; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - pharmacor mycophenolate 250 is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. pharmacor mycophenolate 250 is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.